Our findings indicate that SAMD9 is co-expressed with these immune inhibitory molecules (PD-L1, IDO1) within immunosuppressive tumor subset, potentially attributed to sustained IFN stimulation. This evidence concerns the gene SAMD9 and neoplasm.